Infectious Disease
Accelerate assay development from concept through validation for research and clinical solutions
Addressing Critical Public Health Problems
Developing diagnostic assays for infectious diseases presents unique challenges, including detecting low-titer pathogens, differentiating among closely related organisms, and rapidly adapting to novel, emerging, and evolving threats. Reliable diagnostic and research tools are essential for guiding patient care, controlling outbreaks, and strengthening public health preparedness.
MRIGlobal combines state-of-the-art CAP/CLIA laboratories, BSL-2 and BSL-3 high-containment facilities, and extensive IVD expertise to advance infectious disease solutions. Our multidisciplinary teams design, develop, and optimize assays while performing rigorous analytical verification and clinical validation in environments that support both routine clinical testing and research involving high-consequence pathogens. By integrating scientific, regulatory, and operational expertise, we overcome technical and compliance challenges, which can help accelerate development timelines, and deliver robust, high-confidence diagnostic solutions for clinical and research applications.
Driving Critical Public Health Efforts
BSL-3 Research Labs
Perform testing with high-consequence pathogens in BSL-3 labs to support biodefense and global health.
Complex Clinical Matrices
Develop robust assays for complex clinical samples with built-in controls for confidence in test results.
Emerging Pathogen Detection
Rapid assay development to pivot and identify novel and emerging infectious disease threats.
Mobile Laboratory Deployment
Develop and deploy mobile laboratories for rapid infectious disease testing in outbreak settings.
Field-Forward Diagnostics
Ruggedize IVD solutions that enable detection in remote, austere, and outbreak environments.
Outbreak Response Diagnostics
Accelerate assay development and validation to achieve regulatory approval during public health emergencies.
Multiplex Infectious Disease Testing
Design assays capable of detecting multiple pathogens simultaneously.
Biodefense and Pandemic Preparedness
Deliver diagnostic capabilities that strengthen national preparedness and enhance threat detection.
Research Use Only (RUO) Assay Development
Create robust RUO assays that advance infectious disease research, biomarker discovery, and translational science initiatives.
